Literature DB >> 3581471

Quantification of human apolipoprotein E in plasma and lipoprotein subfractions by a non-competitive enzyme immunoassay.

M Koffigan, I Kora, V Clavey, J M Bard, J Chapman, J C Fruchart.   

Abstract

A non-competitive enzyme linked immunosorbent assay (ELISA) has been developed to quantitate apolipoprotein E (Apo E) concentrations in serum and in isolated lipoproteins. Microtiter plates coated with affinity-purified antibodies to Apo E were used and the Apo E bound to the plates was estimated with peroxidase-labelled antibodies to Apo E. The average concentration of Apo E in the serum from normolipidemic subjects (n = 132) was 54 +/- 19 mg/l. The within and between assay coefficients of variation were 4.65 and 7.08%, respectively. The standard curves for Apo E in serum, in VLDL and in HDL were parallel. There was a good correlation (r = 0.81) between estimation of Apo E by our assay and that by electroimmunoassay. Assay sensitivity (1 ng of Apo E) was sufficient to enable a study of the distribution of Apo E in plasma lipoproteins separated by density gradient ultracentrifugal fractionation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581471     DOI: 10.1016/0009-8981(87)90243-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group.

Authors:  B Jacotot; J D Banga; P Pfister; M Mehra
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.